General

Showing 2113–2128 of 2301 results

Article: Systemic capillary leak syndrome as a prodrome of extranodal natural killer (NK)/T-cell lymphoma
€3.03 Add to cart
Article: Systemic chemotherapy regimens in early breast cancer patients: updated recommendations from the BSMO breast cancer task force
€3.03 Add to cart
Article: Systemic mastocytosis: overview and new insights in prognosis and therapy
€3.03 Add to cart
Article: Systemic mastocytosis: Overview of recent updates and novel therapies
€3.03 Add to cart
Article: Systemic treatment for basal cell carcinoma of the skin
€3.03 Add to cart
Article: T-cell/histiocyte-rich large B-cell lymphoma: review on pathologic diagnosis, current therapeutic options and new targets for therapy
€3.03 Add to cart
Article: Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS)
€3.03 Add to cart
Article: Targeted next generation sequencing in myeloid neoplasms
€3.03 Add to cart
Article: Targeted therapies in melanoma
€3.03 Add to cart
Article: Targeted therapies in multiple myeloma: new antibodies and CAR-T cells
€3.03 Add to cart
Article: Targeted therapy for the treatment of head and neck squamous cell carcinomas: hopes and pitfalls
€3.03 Add to cart
Article: Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
€3.03 Add to cart
Article: Targeting the immune system in MDS and MPN: – Part 2
€3.03 Add to cart
Article: TCR-based T cell immunotherapy for AML: Multidimensional aids in optimising treatment and patient identification
€3.03 Add to cart
Article: Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy
€3.03 Add to cart
Article: The 13 Belgian symposium on the integration of molecular biology advances into oncology clinical practice (BSMO/Bordet meeting)
€3.03 Add to cart

Article: Systemic capillary leak syndrome as a prodrome of extranodal natural killer (NK)/T-cell lymphoma

Article: Systemic chemotherapy regimens in early breast cancer patients: updated recommendations from the BSMO breast cancer task force

Article: Systemic mastocytosis: overview and new insights in prognosis and therapy

Article: Systemic mastocytosis: Overview of recent updates and novel therapies

Article: Systemic treatment for basal cell carcinoma of the skin

Article: T-cell/histiocyte-rich large B-cell lymphoma: review on pathologic diagnosis, current therapeutic options and new targets for therapy

Article: Targeted next generation DNA sequencing for the detection of clonal haematopoiesis in idiopathic cytopaenia of undetermined significance (ICUS)

Article: Targeted next generation sequencing in myeloid neoplasms

Article: Targeted therapies in melanoma

Article: Targeted therapies in multiple myeloma: new antibodies and CAR-T cells

Article: Targeted therapy for the treatment of head and neck squamous cell carcinomas: hopes and pitfalls

Article: Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)

Article: Targeting the immune system in MDS and MPN: – Part 2

Article: TCR-based T cell immunotherapy for AML: Multidimensional aids in optimising treatment and patient identification

Article: Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy

Article: The 13 Belgian symposium on the integration of molecular biology advances into oncology clinical practice (BSMO/Bordet meeting)